Shionogi & Co., Ltd. (SGIOF)
OTCMKTS
· Delayed Price · Currency is USD
15.00
-1.23 (-7.58%)
At close: Feb 28, 2025
Shionogi & Employees
Shionogi & had 4,959 employees as of March 31, 2024. The number of employees decreased by 721 or -12.69% compared to the previous year.
Employees
4,959
Change (1Y)
-721
Growth (1Y)
-12.69%
Revenue / Employee
$585,989
Profits / Employee
$216,264
Market Cap
13.18B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Endo Inc. | 2,931 |
| Elite Pharmaceuticals | 64 |
| Glass House Brands | 413 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 9 |
| Silence Therapeutics | 109 |
| Longduoduo Company | 49 |
Shionogi & News
- 5 weeks ago - Shionogi and Jordan's Guardian Angels Announce First-Ever Human Drug Study for Jordan's Syndrome, an Ultra-Rare Genetic Neurodevelopmental Disorder - Benzinga
- 5 weeks ago - Shionogi & Co., Ltd. 2024 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 5 weeks ago - Shionogi targets JPY550B revenue through QOL focus and global expansion - Seeking Alpha
- 5 weeks ago - Shionogi & Co., Ltd. (SGIOY) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Shionogi & Co. reports 9M results - Seeking Alpha
- 4 months ago - Shionogi & Co., Ltd. (SGIOY) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Antibiotics, an important but tricky business, says Shionogi CEO [Advocacy Lab Content] - EURACTIV.com
- 8 months ago - Shionogi & Co., Ltd. (SGIOY) Q1 2024 Earnings Call Transcript - Seeking Alpha